Table 5.
Plaque Absent | Plaque Present | |
---|---|---|
(n=1322) | (n=473) | |
|
||
Any Infarcts | ||
N events | 309 | 136 |
Model 1 | Reference | 1.20 (0.95, 1.53) |
Model 2 | Reference | 1.14 (0.89, 1.45) |
Lacunar Infarcts | ||
N events | 225 | 94 |
Model 1 | Reference | 1.07 (0.82, 1.40) |
Model 2 | Reference | 1.03 (0.78, 1.36) |
Cortical Infarcts | ||
N events | 130 | 58 |
Model 1 | Reference | 1.18 (0.86, 1.64) |
Model 2 | Reference | 1.11 (0.80, 1.55) |
Any Microbleeds | ||
N events | 316 | 116 |
Model 1 | Reference | 1.03 (0.80, 1.32) |
Model 2 | Reference | 0.99 (0.77, 1.28) |
Subcortical Microbleeds | ||
N events | 258 | 92 |
Model 1 | Reference | 0.97 (0.74, 1.27) |
Model 2 | Reference | 0.94 (0.72, 1.24) |
Lobar Microbleeds | ||
N events | 110 | 46 |
Model 1 | Reference | 1.24 (0.86, 1.79) |
Model 2 | Reference | 1.15 (0.79, 1.67) |
Inverse probability weighting was used.
Model 1: adjusted for age, sex, race/center, education, APOE ε4
Model 2: adjusted for model 1 plus body mass index, systolic blood pressure, smoking status, pack-years of smoking, antihypertensive medications, diabetes